Seizures in Alzheimer’s disease

Slides:



Advertisements
Similar presentations
Epilepsy in the Elderly:
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Department of Neurology, Mayo Clinic Arizona
Alzheimer’s Disease Edwin Onattu P. 3.
A. LeBron Paige, M.D. Clinical Associate Professor Department of Neurology A. LeBron Paige, M.D. Clinical Associate Professor Department of Neurology Iowa.
Frontotemporal Dementia
Abstract: INTRODUCTION The neuropathologic changes associated with Alzheimer disease (AD) have long been known to occur in people with Down syndrome (DS)
Alzheimer’s Disease By Juan Escobar Per: 4. Alzheimer’s Disease  A common form of dementia of unknown cause, usually beginning in late middle age, characterized.
© 2014 Direct One Communications, Inc. All rights reserved. 1 Treating the New-Onset Epilepsy Patient Ching Y. Tsao, MD Emory University Hospital, Atlanta,
Significance of White Matter Hyperintensities in MCI Charles DeCarli University of California at Davis Alzheimer’s Disease Center Imaging of Dementia and.
Mild Cognitive Impairment
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Diagnosing Seizures and Epilepsy
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Memantine in Clinical Practice – Results of an Observational Study Calabrese P., Essner U. and Förstl H. Dementia and Geriatric Cognitive Disorders 2007;
Risk of Developing Alzheimer’s Disease in Persons with MCI
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Why Physicians Do Not Diagnose Alzheimer’s Disease Mark A. Sager, MD Professor of Medicine and Population Health Sciences Director, Wisconsin Alzheimer’s.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.
MCI Conversion to Dementia: Clinic and Community-Based Studies
Epidemiological and Pharmacoeconomic Aspects of Alzheimer‘s Disease and Dementia.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Amyotrophic lateral sclerosis
Epilepsy in Down’s Syndrome Dr Sameer Zuberi Paediatric Neurologist Fraser of Allander Neurosciences Unit Royal Hospital for Sick Children Glasgow.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Alzheimer’s Disease: Advances and Hope Trey Sunderland, M.D. Chief, Geriatric Psychiatry Branch National Institute of Mental Health Bethesda, Maryland.
The clinical research of early diagnosis and ultimately the treatment of Alzheimer’s disease 許一仁 董冠廷 詹鎮遠 陳柏廷.
Update and Thank you to participants Bradley Hyman MD PhD Director, Mass ADRC ViceChair, Neurology, Massachusetts General Hospital.
Cognitive Development Dementia. Stages: Preclinical First sign: memory loss for the familiar First sign: memory loss for the familiar Biological changes.
Alzheimer’s Disease (AD)
The role of Nutrition in Geriatric Mental Health Chih-Chiang Chiu, M.D., Ph.D. Department of Psychiatry, Taipei City Psychiatric Center.
© 2016 Direct One Communications, Inc. All rights reserved. 1 Obstacles to Epilepsy Diagnosis: If You Don’t Ask, They Won’t Tell Pawan V. Rawal, MD, MHA.
Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Early Childhood Epilepsy Severity Scale (E-CHESS) Humphrey A et al. Epilepsy Research (2008) 79: 139— Frequency of seizures 2. Time period over.
The Malfunctioning Mind: Degenerative Diseases of the Brain
DEMENTIA Shenae Whitfield & Kate Maddock.
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
Hadley KEY SLIDES 9-5 7:45-8:15 PM
Use of Amyloid PET Scan in Early Diagnosis of Alzheimer’s Disease in a Secondary Care Memory Clinic Niki Schoonenboom, MD PhD1, Mohammed Akarriou, MD2;
Are BZDs a Good or a Bad Idea?
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Poststroke dementia Vikas Dhikav,
Perceived Caregiver Stress in Alzheimer’s disease and Mild Cognitive Impairment Vikas Dhikav, Pinki Mishra, Arjun Kumar Singhal*, Dolly Prajapati**, Kuljeet.
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
Imaging AD Progression Amyloid Imaging Agents.
Alzheimer’s Disease 1 in 9 people in the US aged 65 and older
Somatic Symptom Disorders
Nat. Rev. Neurol. doi: /nrneurol
Cognitive Disorders and Aging
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Progress Report on Alzheimer’s Disease
Figure 2 Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative.
Early Dementia Distinguishing AD From MCI
Late Adulthood: Cognitive Development
New FDA Guidance on Early Alzheimer’s Disease
Probing the Biology of Alzheimer's Disease in Mice
ALZHEIMER´S.
Alzheimer's.
Receiver operating characteristics curves showing discrimination between patients with dementia of the Alzheimer type (at time of diagnosis) and non-demented.
Imogen Milner MS/Epilepsy SCN May 2018
Acute and Chronic Seizures in Patients Older Than 60 Years
ROC curve for the TYM-MCI, ACE-R and MMSE in the separation of patients with aMCI/AD from those with SMC. ACE-R, Addenbrooke’s Cognitive Examinations;
Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;
Presentation transcript:

Seizures in Alzheimer’s disease Vikas Dhikav, MBBS (Rohtak), MD (3-years AIIMS) , PhD (Neurology, PGIMER Delhi), Fellowship Clinical Neuropsychopharmacology, Director, Memory Clinic Delhi, www.memoryclinicdelhi.com Seizures in Alzheimer’s disease

Alzheimer’s disease Most common cause of dementia. Affects around 1 Crore people in India! PrecursorMild Cognitive Impairment (MCI)

Risk AD  upto 10-fold increased risk of developing seizures. Seziurescommon in AD   Hesdorffer DC et al., Neurology. 1996;46:727–730.

Incidence AD and other neurode-generative conditions presumed etiology 10% of new onset epilepsy in patients older than 65 years. Hauser WA, Annegers JF, Kurland LT.  Epilepsia. 1993;34:453–468.

Prevalence Lifetime prevalence seizures with AD1.5 to 64 percent Hauser HA, Neurology, 1986

Why AD has seizures? AD risk for late-onset seizures and neuronal network abnormalities.  Born, Neuroscience, 2014

Sporadic Vs Familial More common in sporadic form of AD. 

Common problem!  Nonconvulsive network abnormalities, seizures and other electroencephalographic abnormalities, more commonly found in patients than previously thought.  Hauser HA, Neurology, 1986

Genetics More common imutations in PSEN1, PSEN2, or APP, as well as with APP duplication Born, Neuroscience, 2014

Pathophysiology The amyloid-β possible link AD and seizures. 

Seizures worsen AD Seizures contribute to cognitive impairments characteristic of AD, such as amnestic wandering. 

Experimental evidence Antiepileptic drugs rescue cognitive deficits in AD mouse models and human patients.

Epilepsy and AD Epilepsy Alzheimer’s disease Potential research area

Potential Rx targets Better Treatment Alzheimer’s disease Neuronal hyperexcitability Neuronal abnormalities Nikolas et al., Arch Neurol. 2009; 66(8): 992–997.

World experience Occur in about 10%, 10 times more common than reference population. Can occur anytime. Generalized seizures occur early. Myoclonuslate seziures. Hauser HA, Neurology, 1986

Indian experience Category Sample size (n) =171 Age (Years) Sex MMSE AD 75 75±5 M:F=60:15 18±5 MCI 96 67±7 M:F=76:20 24±2

Proportion of seizures in AD/MCI

Indian experience… Category Seizures Duration of illness (Years) Drug Treatment AD GTCS (7), Partial (2) 3.6±3 Valproate/Levitiracetam MCI GTCS (4), Partial (2) 2.5 ±2

Epilepsy and AD overlap Do epilepsy and AD share pathophysiology? Dionysios Pandis, Epilepsy Curr. 2012; 12(5): 184–187.

Manifestations The diagnosis of seizures in AD not easyunderestimation. “Funny” or “unusual” behaviors of demented patients seizuresoverestimation of seizure rates.

Seizure types Generalizedmost common Partial seizures

Predictors Seizure prevalence increase with AD duration. Onset of seizures later stages of the disease.

Be aware!  Patients with dementia nonepileptic episodes of inattention or confusion as well as syncope or near-syncope. Nikolas et al., Arch Neurol. 2009; 66(8): 992–997.

Treatment Choice of AEDs empirical based on side effect profiles.